Biofrontera (BFRI) Operating Expenses (2020 - 2026)
Biofrontera (BFRI) posted quarterly Operating Expenses of $12.5 million for Q4 2025, down 12.12% year-over-year from $14.3 million in Q4 2024, and down 5.47% quarter-over-quarter from $13.3 million in Q3 2025.
Biofrontera (BFRI) Operating Expenses (2020 - 2026) Analysis & Trends
Biofrontera's Operating Expenses history runs 6 years deep, the most recent figure standing at $12.5 million for Q4 2025.
- In Q4 2025, Operating Expenses fell 12.12% year-over-year to $12.5 million; the TTM figure through Dec 2025 stood at $53.1 million (down 2.72% YoY), while the FY2025 annual figure was $53.1 million, down 2.71% from the prior year.
- Operating Expenses for Q4 2025 stood at $12.5 million, down from $13.3 million in the prior quarter.
- The five-year high for Operating Expenses was $20.4 million in Q3 2021, with the low at $8.0 million in Q3 2022.
- The 5-year median for Operating Expenses is $13.3 million (2024), against an average of $13.0 million.
- The sharpest annual moves came in 2021 and 2022: Operating Expenses surged 265.24% in 2021, then plunged 61.05% in 2022.
- Biofrontera's Operating Expenses stood at $11.0 million in 2021, then surged by 42.69% to $15.8 million in 2022, then retreated by 8.27% to $14.5 million in 2023, then retreated by 1.31% to $14.3 million in 2024, then slipped by 12.12% to $12.5 million in 2025.
- Business Quant data shows BFRI's Operating Expenses at $12.5 million in Q4 2025, $13.3 million in Q3 2025, and $14.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Biofrontera | 18.87 Mn | 14.16 Mn | 9.59 Mn | 12.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.53 Mn |
| Dec 31, 2025 | 12.54 Mn |
| Sep 30, 2025 | 13.27 Mn |
| Jun 30, 2025 | 14.11 Mn |
| Mar 31, 2025 | 13.14 Mn |
| Dec 31, 2024 | 14.27 Mn |
| Sep 30, 2024 | 13.97 Mn |
| Jun 30, 2024 | 12.91 Mn |
| Mar 31, 2024 | 13.38 Mn |
| Dec 31, 2023 | 14.46 Mn |
| Sep 30, 2023 | 13.52 Mn |
| Jun 30, 2023 | 14.55 Mn |
| Mar 31, 2023 | 14.23 Mn |
| Dec 31, 2022 | 15.76 Mn |
| Sep 30, 2022 | 7.96 Mn |
| Jun 30, 2022 | 10.67 Mn |
| Mar 31, 2022 | 12.86 Mn |
| Dec 31, 2021 | 11.05 Mn |
| Sep 30, 2021 | 20.44 Mn |
| Jun 30, 2021 | 9.54 Mn |